You're frustration is understandable. And I'm sitting here wishing I hadn't used my last farthing buying GNBT over the last week at .23 or .24. Geez Louise what a deal at sub-.20. Anyway, to your point, it would be counterproductive if Joe waived the GNBT flag before he could clearly say, 'The iikey/peptides work and here's the data that proves it, and now we're going into the clinic'. He can't afford to erode confidence in GNBT any further than it is already. Best to remain silent until he has something solid to offer.

My question to Joe: if you need investors to pony up $$ so you can finish with the peptide investigation, why aren't you asking?